Evidence map›Paper›PMID 39349478›Full record

ArticleNature communications2024

Contrasting genomic epidemiology between sympatric Plasmodium falciparum and Plasmodium vivax populations.

Philipp Schwabl, Flavia Camponovo, Collette Clementson, Angela M Early, Margaret Laws, David A Forero-Peña, Oscar Noya, María Eugenia Grillet, Mathieu Vanhove, Frank Anthony and 6 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Malaria control and the unexpected spread of diagnostic-resistantbioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Mixed malaria infections: A critical review and Detect-Characterise-Act surveillance framework.Current research in parasitology & vector-borne diseases · 2026
    Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Philipp Schwabl *Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA.ORCID 0000-0002-1244-945X
Flavia Camponovo *Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Collette Clementson *National Malaria Program, Ministry of Health, Georgetown, Guyana.
Angela M EarlyInfectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Margaret LawsDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
David A Forero-PeñaBiomedical Research and Therapeutic Vaccines Institute, Ciudad Bolívar, Venezuela.
Oscar NoyaInstitute of Tropical Medicine, Faculty of Medicine, Central University of Venezuela, Caracas, Venezuela.
María Eugenia GrilletInstitute of Zoology and Tropical Ecology, Central University of Venezuela, Caracas, Venezuela.
Mathieu VanhoveDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Frank AnthonyNational Malaria Program, Ministry of Health, Georgetown, Guyana.
Kashana JamesNational Malaria Program, Ministry of Health, Georgetown, Guyana.
Narine SinghNational Malaria Program, Ministry of Health, Georgetown, Guyana.
Horace CoxNational Malaria Program, Ministry of Health, Georgetown, Guyana.
Reza Niles-RobinNational Malaria Program, Ministry of Health, Georgetown, Guyana.ORCID 0000-0001-5948-4335
Caroline O BuckeeCenter for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.ORCID 0000-0002-8386-5899
Daniel E NeafseyDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA. neafsey@broadinstitute.org.ORCID 0000-0002-1665-9323

Funding

Viral Genomics: evolution, spread, and host interactionsU19AI110818 · NIAID · BROAD INSTITUTE, INC. · PI EARL, ASHLEE MIRIAM · 2014 to 2024
$66.5M
NIAID NIH HHS U19 AI110818RCUK | Engineering and Physical Sciences Research Council (EPSRC) EP/T003782/1Scottish Funding Council (SFC) SFC/AN/12/2017U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) U19AI110818
6 · The paper itself

Abstract

The malaria parasites Plasmodium falciparum and Plasmodium vivax differ in key biological processes and associated clinical effects, but consequences on population-level transmission dynamics are difficult to predict. This co-endemic malaria study from Guyana details important epidemiological contrasts between the species by coupling population genomics (1396 spatiotemporally matched parasite genomes, primarily from 2020-21) with sociodemographic analysis (nationwide patient census from 2019). We describe how P. falciparum forms large, interrelated subpopulations that sporadically expand but generally exhibit restrained dispersal, whereby spatial distance and patient travel statistics predict parasite identity-by-descent (IBD). Case bias towards working-age adults is also strongly pronounced. P. vivax exhibits 46% higher average nucleotide diversity (π) and 6.5x lower average IBD. It occupies a wider geographic range, without evidence for outbreak-like expansions, only microgeographic patterns of isolation-by-distance, and weaker case bias towards adults. Possible latency-relapse effects also manifest in various analyses. For example, 11.0% of patients diagnosed with P. vivax in Greater Georgetown report no recent travel to endemic zones, and P. vivax clones recur in 11 of 46 patients incidentally sampled twice during the study. Polyclonality rate is also 2.1x higher than in P. falciparum, does not trend positively with estimated incidence, and correlates uniquely to selected demographics. We discuss possible underlying mechanisms and implications for malaria control.

Indexed as

Malaria, FalciparumMalaria, VivaxPlasmodium falciparumPlasmodium vivaxAdolescentAdultChildChild, PreschoolFemaleGenetic VariationGenome, ProtozoanGenomicsHumansMaleMiddle AgedMolecular Epidemiology

Identifiers

PMID39349478
PMCPMC11442626

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.